Mechanistic target of rapamycin complex 1 (TORC1) integrates nutrient signals to control cell growth and organismal homeostasis across eukaryotes [1] [2] [3] [4] . The evolutionarily conserved GATOR complex regulates mTORC1 signalling through Rag GTPases, and GATOR1 displays GTPase activating protein (GAP) activity for RAGA and RAGB (RAGA/B) and GATOR2 has been proposed to be an inhibitor of GATOR1 5, 6 . Furthermore, the metazoan-specific SESN proteins function as guanine nucleotide dissociation inhibitors (GDIs) for RAGA/B, and interact with GATOR2 with unknown effects 7-9 . Here we show that SZT2 (seizure threshold 2), a metazoan-specific protein mutated in epilepsy [10] [11] [12] [13] , recruits a fraction of mammalian GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex with an essential role in GATOR-and SESN-dependent nutrient sensing and mTORC1 regulation. The interaction of SZT2 with GATOR1 and GATOR2 was synergistic, and an intact SOG complex was required for its localization at the lysosome. SZT2 deficiency resulted in constitutive mTORC1 signalling in cells under nutrient-deprived conditions and neonatal lethality in mice, which was associated with failure to inactivate mTORC1 during fasting. Hyperactivation of mTORC1 in SZT2-deficient cells could be partially corrected by overexpression of the GATOR1 component DEPDC5, and by the lysosome-targeted GATOR2 component WDR59 or lysosome-targeted SESN2. These findings demonstrate that SZT2 has a central role in dictating GATOR-dependent nutrient sensing by promoting lysosomal localization of SOG, and reveal an unexpected function of lysosome-located GATOR2 in suppressing mTORC1 signalling through SESN recruitment.
. Whereas all GATOR orthologues present in yeast are components of the Seh1-associated (SEA) complex [21] [22] [23] [24] , GATOR1 and GATOR2 are loosely associated in mammalian cells 5 , implying that additional component(s) may exist in metazoans that modulate the interaction of GATOR1 and GATOR2.
Mutations in the metazoan-specific SZT2 gene cause epilepsy [10] [11] [12] [13] , a disease frequently associated with mTORC1 hyperactivation 25 . We identified SZT2 as a component of the SESN2 interactome (see below and data not shown). Deletion of SZT2 using single-guide RNAs rendered mTORC1 signalling insensitive to amino acid deprivation, as indicated by phosphorylation of S6K, S6 and 4E-BP1 ( Fig. 1a and Extended Data Fig. 1a ). Furthermore, neither glucose deprivation nor combined depletion of amino acids and glucose could inactivate mTORC1 in SZT2-deficient cells, although serum starvation could ( Fig. 1b and Extended Data Fig. 1b ). SZT2-deficient cells were larger than control cells, but SZT2 overexpression could not inhibit mTORC1 activation (Extended Data Fig. 1c, d ), demonstrating that SZT2 is necessary, but not sufficient to suppress the nutrient arm of mTORC1 signalling. Indeed, SZT2 deficiency resulted in constitutive mTORC1 localization at the lysosome irrespective of nutrient status ( Mass spectrometry experiments showed that GATOR components were SZT2-interacting proteins (Extended Data Fig. 2a ). To investigate these interactions, a Flag tag was knocked into the SZT2 locus in HEK293T cells (Extended Data Fig. 2b-e) . Using Flag-tagged red fluorescent protein (RFP) and DEPDC5 as controls, we found that Flag-SZT2 pulled down NPRL3 and NPRL2 as well as MIOS and WDR24, but did not pull down Rag GTPases (Fig. 2a) . Consistent with previous findings that GATOR1 and GATOR2 are mostly independent complexes 5 , endogenous WDR24 co-immunoprecipitated efficiently with WDR59 and MIOS, but not with NPRL2 or NPRL3, whereas NPRL3 pulled down NPRL2, but not WDR59, WDR24 or MIOS (Fig. 2b) . Nonetheless, SZT2 co-immunoprecipitated with both GATOR1 and GATOR2 (Fig. 2b) . Although SESN2 was undetectable in the immunoprecipitate of SZT2, SESN2 pulled down GATOR2, GATOR1 and SZT2 (Fig. 2b) .
Size-exclusion chromatography (SEC) experiments showed that whereas GATOR components were broadly distributed, SZT2 was enriched in fractions with a peak molecular weight around 1.06 MDa (Fig. 2c) , which is close to the size of a predicted trimeric SZT2-GATOR1-GATOR2 complex (approximately 1.03 MDa). Indeed, the purified SZT2 complex contained both GATOR1 and GATOR2 components (Extended Data Fig. 2f, g ). Furthermore, WDR24 pulled down NPRL3 only in SZT2-containing SEC fractions (Fig. 2c, d) , and SZT2 deficiency depleted NPRL2 and NPRL3 from these fractions (Fig. 2c) . In a sucrose density gradient centrifugation assay, cosedimentation of GATOR1 and GATOR2 components at high sucrose density was also diminished in SZT2-deficient cells (Extended Data  Fig. 2h ). Nonetheless, GATOR2 mobility in SEC did not substantially change upon SZT2 loss (Fig. 2c) , implying that additional GATOR2-containing high-molecular-weight complexes exist.
SZT2-dependent GATOR1-GATOR2 interaction was validated by crosslinking-assisted immunoprecipitation with total cell lysate as an input (Fig. 2e) . Furthermore, the SZT2-GATOR2 interaction was lost in the absence of NPRL3, and the SZT2-GATOR1 interaction was substantially diminished in the absence of WDR59, WDR24 and MIOS (Fig. 2f) , suggesting synergistic binding among SZT2, GATOR1 and GATOR2. Collectively, these observations reveal multiple GATORcontaining complexes (Fig. 2g) , and show that SZT2 unites a pool of GATOR1 and GATOR2 to form SOG.
The SZT2-GATOR interaction was not modulated by amino acids, and the stable SOG complex did not dissociate during washes with 1.5 M sodium chloride (Fig. 2b , e, f and Extended Data Fig. 3a, b) . SZT2 did not bind to the mTORC1-modulating amino acids leucine, arginine or glutamine, and SZT2 deficiency did not change the ability of SESN2 to bind to leucine 20 (Extended Data Fig. 3c, d ). Furthermore, interaction of SESN2 with GATOR2 was unchanged in the absence of SZT2, and SESN2 overexpression did not affect the interaction between SZT2, GATOR1 and GATOR2 (Extended Data Fig. 3e, f) . Thus, SZT2 does not appear to be an amino acid sensor and SESN2 probably does not regulate mTORC1 signalling by disrupting SOG.
SZT2 is a protein with a length of 3,432 amino acids with no discernible homology to other proteins. A C-terminal deletion mutant of SZT2(Δ2,335-3,432) retained GATOR1 binding activity, but could not rectify mTORC1 signalling in SZT2-deficient cells (Extended Data  Fig. 4a, b, f) . Deletion of a small portion (amino acids 1,083-1,189) within the GATOR1-binding region (amino acids 935-1,734) created a SZT2 mutant, SZT2(Δ1,083-1,189), that had minimal GATOR1 binding activity, but that had preserved interaction with GATOR2 (Extended Data Fig. 4c, d ). However, neither expression of SZT2(Δ1,083-1,189) nor co-expression of SZT2(935-1,734) and SZT2(Δ1,083-1,189) could rescue mTORC1 hyperactivation in SZT2-deficient cells (Extended Data Fig. 4e ), suggesting that an intact SOG complex is required for SZT2 control of mTORC1 signalling.
SZT2 was co-localized with the lysosome markers LAMP1 and LAMP2 and the late endosome and lysosome maker RAB7, but not with the early endosome marker EEA1 or the peroxisome marker PMP70 (ref. 26) (Fig. 3a and Extended Data Fig. 5a, c-f ). In addition, a pool of WDR59 was co-localized with SZT2 at the lysosome (Extended Data Fig. 5b, c, f) . Localization of SZT2 at the lysosomes was disrupted in NPRL3-deficient cells, and reduced in WDR59-, WDR24-and Letter reSeArCH MIOS-deficient cells ( Fig. 3a-d) . Furthermore, lysosomal localization of WDR59 was abolished in the absence of SZT2, NPRL3 or DEPDC5 ( To investigate how SZT2 organizes GATOR to control mTORC1 signalling, we performed functional rescue experiments. Overexpression of DEPDC5, but not SESN2, partially inhibited mTORC1 activation in SZT2-deficient cells (Fig. 4a) , suggesting that SZT2 represses mTORC1 in part through GATOR1 and that SESN2 requires SZT2 to function. Depletion of WDR24, MIOS or WDR59, or deletion of both WDR24 and MIOS led to diminished mTORC1 signalling in control cells, but not in SZT2-deficient cells (Extended Data Fig. 6a, b) . However, mTORC1 signalling was partially rectified in SZT2-deficient cells when WDR24, WDR59 and MIOS were deleted altogether ( Fig. 4b and Extended Data Fig. 6c ), which is reminiscent of the redundant functions of their orthologues in yeast 6 . Furthermore, depletion of SEH1L inhibited mTORC1 signalling in control cells, and partially suppressed mTORC1 activation in SZT2-deficient cells (Extended Data Fig. 6d ). These observations show that GATOR2 can promote mTORC1 signalling through SZT2-independent mechanisms, but that to function optimally, GATOR2 requires SZT2.
To investigate whether mislocalization of GATOR2 in SZT2-deficient cells might affect mTORC1 signalling, we targeted GATOR2 components back to the lysosome ( Fig. 4c and data not shown). Expression of neither wild-type nor lysosome-targeted WDR59, WDR24 or MIOS substantially affected mTORC1 signalling in control cells (Extended Data Fig. 7a, b) . However, expression of lyso-WDR59 and, to a lesser extent, lyso-WDR24 or lyso-MIOS inhibited mTORC1 signalling in SZT2-deficient cells (Extended Data Fig. 7c, d ). This unexpected inhibitory function of lysosomal WDR59 was corroborated by the observation that WDR59 deficiency resulted in partial resistance to mTORC1 inactivation triggered by nutrient deprivation in HEK293T cells and mouse embryonic fibroblasts (MEFs) (Extended Data Fig. 7e-g ).
Depletion of endogenous WDR59 potentiated mTORC1 inhibition triggered by lyso-WDR59 in SZT2-deficient cells (Extended Data Fig. 7h ), and lyso-WDR59 almost completely suppressed mTORC1 signalling when endogenous WDR59, WDR24 and MIOS were deleted (Fig. 4d ). In addition, lyso-WDR59 inhibited mTORC1 in GATOR1-deficient cells, but not in cells expressing a constitutively active form of RAGB or lysosome-targeted Raptor ( suppress mTORC1 through SESN recruitment, we expressed lysosometargeted SESN2, and found that lyso-SESN2 inhibited mTORC1 signalling in SZT2-or GATOR1-deficient cells in the absence or presence of GATOR2 (Fig. 4f, g and Extended Data Fig. 8e ). These findings indicate a noteworthy role for SOG-associated GATOR2 in mTORC1 repression via recruitment of SESN to the lysosome.
To investigate the in vivo function of SZT2, we used a mouse strain with a gene-trap mutation of the Szt2 gene 10 . Although Szt2 −/− mice were born at an expected Mendelian ratio, they could not survive to weaning age (Fig. 5a, b and Extended Data Fig. 9a, b) . Indeed, Szt2 −/− neonates displayed enhanced mTORC1 signalling in multiple organs and all died upon fasting (Fig. 5c-e and Extended Data Fig. 9c-e) , and were reminiscent of the phenotypes that developed in RRAGA GTP/GTP mice and SESN-deficient mice 7, 27 . In Szt2 −/− MEFs, mTORC1 could not be repressed by deprivation of amino acids or amino acids plus glucose (Extended Data Fig. 9f-h) , and was constitutively localized at the lysosome (Extended Data Fig. 9i ). By contrast, serum starvation inhibited mTORC1 activation (Extended Data Fig. 9j ), suggesting that there is a specific function of Szt2 in nutrient-dependent mTORC1 signalling.
The identification of SZT2 as a scaffold molecule that combines a portion of GATOR1 and GATOR2 to form lysosomal SOG complexes provides novel insights into the nutrient-sensing pathway in multicellular eukaryotes (Extended Data Fig. 10 ). SZT2 deficiency results in GATOR mislocalization, revealing a notable role for SZT2 in supporting GATOR1 GAP function. Furthermore, SZT2 and GATOR1 act as anchors of SOG to recruit GATOR2 to the lysosome for mTORC1 suppression through recruitment of the SESN family of GDIs. A dual function for GATOR2 in mTORC1 activation and repression implies that GATOR2 may have been adapted to enable robust nutrient sensing in metazoans.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.
Mice, MEFs and cell lines. Szt2
+/− mice (B6.129P2-Szt2 Gt(XH662)Byg /FrkJ.) were obtained from Jackson Laboratory (Stock Number: 010916). Embryonic day (E)19.5 pregnant females from timed breeding were monitored closely. Immediately after the delivery of first pup, a Caesarean section was performed and fetuses were obtained. Successfully resuscitated neonates were counted and placed in a humidified chamber at 30 °C. After fasting, liver, heart and limbs were collected and immediately put into cell-lysis buffer and snap frozen using dry ice and stored at −80 °C. Total cell lysates were prepared after genotyping, and mTORC1 signalling in different organs was determined by immunoblotting. Primary Szt2
and Szt2 −/− MEFs were prepared from E14.5 embryos, primary Wdr59 +/+ and Wdr59 −/− MEFs were prepared from E7 embryos (unpublished data), and all experiments were performed with MEFs that were less than 4 passages. All mice were maintained in a specific-pathogen-free facility and animal experimentation was conducted in accordance with institutional guidelines.
HEK293 cells and HeLa cells were from the ATCC. Cells were maintained in DMEM (25 mM glucose) supplemented with 10% fetal bovine serum (FBS), 100 U ml −1 penicillin and 100 mg ml −1 streptomycin. Cell lines were authenticated and mycoplasma negative. Generation of knockout and knock-in cell lines. To generate gene knockout cell lines, guide RNAs were cloned into LentiCrisprV2 (Addgene 52961). HEK293 or HeLa cells were transfected with plasmids targeting specific genes and selected with puromycin for 3 days. Cells that survived the selection were plated in 96-well plates using a limited dilution method with approximately one cell per well. After two weeks, single-cell clones were expanded and screened by immunoblotting for target protein depletion.
To generate the knock-in allele of SZT2, a guide RNA targeting the first coding exon of SZT2 (sgSZT2-ATG) was cloned into LentiCrisprV2. To insert a Flag tag into this site via homologous recombination, we generated a double-stranded DNA with the Flag coding sequence followed by a GG linker that was flanked on either side by 40 base pairs of the sequence surrounding the SZT2 start codon. Silent mutations were also included to generate a mismatch with the gRNA to prevent retargeting of the modified locus. 100 ng double-stranded DNA along with 2 μg LentiCripsrV2-sgSZT2ATG was transfected into one million HEK293T cells. Cells were selected with puromycin for 3 days. Cells that survived the selection were plated in 96-well plates using a limited dilution method. After two weeks, single-cell clones were expanded and screened by immunoblotting with a Flag antibody. Positive clones were further validated by sequencing of the targeted genomic loci.
The following primers were used to clone sgRNA into LentiCrisprV2 (coding sequence in capitals): sgSZT2-1F caccgCTCTCACCGCAGTAATATTC, sgSZT2-1R aaacGAATAT TACTGCGGTGAGAGc; sgSZT2-2F caccgGCACCCACGTGTCATGCTCC, sgSZT2-2R aaacGGAGCATGACACGTGGGTGCc; sgSZT2-3F caccgGAA GAGTGGCACTCCGCTCT, sgSZT2-3R aaacAGAGCGGAGTGCCACTCTTCc; sgSZT2ATG-F caccgCTCCGGCTCCGGGCGCTCCG, sgSZT2ATG-R aaacCG GAGCGCCCGGAGCCGGAGc; sgRRAGA-F caccgGGATGGCCTCCAGA CACGAC, sgRRAGA-R aaacGTCGTGTCTGGAGGCCATCCc; sgRRAGB-F cac cgTTGTCCTTAGGTGCTGTTGA, sgRRAGB-R aaacTCAACAGCACCTAAG GACAAc; sgWDR24-1F caccgCACGAACTGTTCCTCCTCGA, sgWDR24-1R aaacTCGAGGAGGAACAGTTCGTGc; sgWDR24-2F caccgCGTCCCG CACGCTCTCCGAC, sgWDR24-2R aaacGTCGGAGAGCGTGCGGGACGc; sgMIOS-1F caccgGAAAGGAACGGATGTAGACG, sgMIOS-1R aaacCGTCT ACATCCGTTCCTTTCc; sgMIOS-2F caccgTTGAACTCCCTTGTACAAGA, sgMIOS-2R aaacTCTTGTACAAGGGAGTTCAAc; sgWDR59-1F caccgGCGAT GGAGCAGCGAAAACG, sgWDR59-1R aaacCGTTTTCGCTGCTCCATCGCc; sgWDR59-2F caccgCCAGCCATGACGGCGATGTG, sgWDR59-2R aaacCA CATCGCCGTCATGGCTGGc; sgWDR59-3F caccgACTTGTAAAGGTC TACTCGT, sgWDR59-3R aaacACGAGTAGACCTTTACAAGTc; sgSE H1L-1F caccgGAATCAAATGATAAACTGCG, sgSEH1L-1R aaacCGCAGT TTATCATTTGATTCc; sgSEH1L-2F caccgTTAGCAACCTGTTCCGCAGA, sgSEH1L-2R aaacTCTGCGGAACAGGTTGCTAAc; sgSEH1L-3F caccgATTGG CATTGTACTGCTAGC, sgSEH1L-3R aaacGCTAGCAGTACAATGCCAATc; sgGFP-F caccgGGGCGAGGAGCTGTTCACCG, sgGFP-R aaacCGGTGAA CAGCTCCTCGCCCc; sgNPRL3-1F caccgCAGCCCCATCAGCGTGATTC, sgN PRL3-1R aaacGAATCACGCTGATGGGGCTGc; sgNPRL3-2F caccgCGCCAC CGTGCTGCAGCACG, sgNPRL3-2R aaacCGTGCTGCAGCACGGTGGCGc; sgNPRL3-3F caccgACCTCAAGGAAGCTTATGAC, sgNPRL3-3R aaacGT CATAAGCTTCCTTGAGGTc; sgDEPDC5-1F caccgGACTTGACCTGCAAAAG CAG, sgDEPDC5-1R aaacCTGCTTTTGCAGGTCAAGTCc; sgDEPDC5-2F caccgTGTTAATGTCGTAGACCCTA, sgDEPDC5-2R aaacTAGGGTCTACGA CATTAACAc. Cloning and establishment of stable cell lines. The cDNA of the full-length SZT2 was cloned from HEK293T cells. The cloned SZT2 encoded a 3,432 amino acid protein similar to the predicted SZT2 protein isoform X3 (XP_006710564.1) in the NCBI database, except that amino acid 1,938 in the cloned SZT2 was a threonine rather than isoleucine. This residue is a serine in the mouse Szt2 protein, and the cloned SZT2 was able to rescue the mTORC1 signalling phenotype in SZT2-deficient cells, demonstrating that the cloned SZT2 is a functional protein. To establish SZT2-expressing stable cell lines, SZT2 was subcloned into the lentiviral vector pLJM1 at SalI and EcoRI sites with a Flag tag fused to the N terminus. Lentiviruses were produced in HEK293T cells, and used to infect target cells that were subsequently selected with puromycin. SZT2 was also cloned into pCMV-HA (haemagglutinin) and pCMV-Flag vectors for transient transfection experiments.
To generate lyso-RFP, lyso-WDR59, lyso-WDR24, lyso-MIOS and lyso-SESN2, we modified the pLJM1 vector by insertion of the lysosomal-targeting motif of p18 (also known as LAMTOR1) (MGCCYSSENEDSDQDREERKLLLDPSSPPT KALNGAEPN, cloned from pRK5-HA-p18) upstream of the SalI site. This lysosomaltargeting sequence has been used to target TSC2 to lysosome 28 . The AgeI site upstream of SalI site was eliminated by site-directed mutagenesis, and a new AgeI site was included downstream of the SalI site to facilitate the cloning of cDNAs. RFP and SESN2 were cloned into this modified pLJM1 vector (pLJM1-lyso-Flag) with SalI and EcoRI, WDR59 and MIOS with SalI and AgeI, and WDR24 with SalI and EcoRV.
The following plasmids were obtained from Addgene: pLJM1-Flag-Rap2A Amino acid, glucose and serum starvation and re-stimulation. HEK293T, HEK293E, HeLa and MEFs were maintained in DMEM supplemented with 10% FBS. Cells were plated in 12-well or 6-well plates one day before experiments. On the next day, cells were rinsed once with amino acid-and/or glucose-free DMEM, incubated with amino-acid-and/or glucose-free DMEM supplemented with 10% dialysed FBS (dFBS, Invitrogen) for the indicated time, and stimulated with amino-acid-and glucose-replete DMEM for 10-20 min. For serum starvation, cells were incubated with DMEM without FBS for 24 h. After the treatment, cells were lysed, and protein extracts were prepared for immunoblotting. Amino-acid-and glucose-deficient DMEM medium were from the Media Core Facility of MSKCC, which had the same ingredients as DMEM from Invitrogen (11965092) except amino acids or glucose were absent. Cell lysis and immunoprecipitation. For protein extracts used in immunoblotting, cells were lysed in 1× Cell Lysis Buffer (CST) supplemented with one tablet of EDTA-free protease inhibitor (Roche) per 50 ml and one tablet of PhosSTOP (Roche) per 10 ml. For protein extracts used in immunoprecipitation experiments, cells were lysed with the CHAPS or Triton X-100 lysis buffer (40 mM HEPES (pH 7.4), 0.3% CHAPS or 1% Triton X-100, 10 mM β-glycerol phosphate, 10 mM pyrophosphate and 2.5 mM MgCl 2 ) supplemented with the EDTA-free protease inhibitor and PhosSTOP. The soluble fractions of cell lysates were isolated by centrifugation at 14,000 r.p.m. for 6 min. The anti-Flag or anti-HA beads (Sigma) were washed three times with lysis buffer. Subsequently, 20 μl of 50% slurry of the beads was added and incubated with the lysates for 1-3 h at 4 °C. The beads were washed three times with lysis buffer containing 150 mM NaCl. For immunoprecipitation of endogenous protein complexes with antibodies (described above), the antibodies (2 μl per sample) were incubated with lysate for 2 h at 4 °C, and 30 μl of 50% slurry of pre-cleared protein-G beads was added and incubated for another hour at 4 °C. The beads were washed three times with lysis buffer containing 500 mM NaCl, and once with lysis buffer containing 150 mM NaCl. Immunoprecipitated proteins were denatured by the addition of 30-60 μl of sample buffer and boiling for 5 min, resolved by SDS-PAGE, and analysed by immunoblotting.
To detect the interaction between GATOR1 and GATOR2 in total cell lysate, DSP crosslinker was used to enhance the sensitivity of the assay. Cells were rinsed once with PBS before subjected to crosslinking with DSP. 20 mg DSP was dissolved in 1 ml DMSO to a final concentration of 50 mM (100× stock solution), and then diluted into 100 ml of PBS with 1 mM MgCl 2 and 0.1 mM CaCl 2 . Cells were incubated with the 1× crosslinking DSP solution for 20 min at room temperature. After incubation, cells were rinsed once with PBS, and incubated with 20 mM Tris in PBS for 5 min to quench the excessive DSP. Subsequently, cells were rinsed twice with PBS and lysed with 1% Triton X-100 lysis buffer. Anti-Flag M2 immunoprecipitation was performed as described above. Immunofluorescence. HEK293T, HeLa, and MEFs were plated on poly-d-lysine Cellware 12-mm coverslips (BD Biosciences). On the next day, cells were either amino acid starved, or starved, followed by amino acid re-stimulation. At the end of treatment, cells were rinsed once with PBS, and fixed for 15 min with 4% paraformaldehyde in PBS at room temperature, and all following steps were also carried out at room temperature. The slides were rinsed twice with PBS, and the cells were permeabilized with 0.1% Triton X-100 in PBS for 5 min. After rinsing twice with PBS, the slides were incubated with primary antibodies in 5% normal donkey serum for 1-3 h at room temperature, rinsed four times with PBS, and incubated with secondary antibodies produced in donkey (diluted 1:1,000 in 5% normal donkey serum) for 1 h at room temperature in the dark. Slides were washed four times with PBS, mounted on glass coverslips using ProLong Gold (Invitrogen), and imaged on a Leica-Upright Point scanning confocal microscope with a 63× oil lens. For each sample, at least 10 different fields were scanned. Quantifications were from approximately 100-150 cells per sample.
Owing to the low abundance of SZT2 protein, the signal of anti-Flag staining in SZT2
Flag/− cells was undetectable with the conventional immunofluorescence staining protocol described above (data not shown), we therefore instead used the Tyramide SuperBoost Kit (Invitrogen, B40941) to amplify the signal. In brief, cells were grown and treated as described above. After fixation and permeabilization, cells were incubated with 3% hydrogen peroxide solution for 1 h to quench the endogenous HRP activity. Cells were then block with 10% goat serum for 1 h, and incubated with anti-Flag M2 antibody (Sigma, F1804, 1:200 dilution) for 2 h. Cells were washed three times (10 min each) with PBS (2 ml per wash), and incubated with poly-HRP-conjugated goat-anti-mouse secondary antibody for 1 h. Cells were washed with PBS and incubated with tyramide working solution for 3 min to label target protein. Then cells were counterstained with other proteins using the standard protocol described above.
In Extended Data Fig. 5c -e, anti-Flag and anti-LAMP2, as well as anti-Flag and anti-PMP70, were all mouse monoclonal antibodies. The co-localization between Flag-SZT2 and LAMP2 was not owing to signal from mouse anti-Flag staining (which was labelled first), because (1) the anti-Flag staining in HEK293T SZT2
Flag/− cells was undetectable with the conventional immunofluorescence staining protocol, (2) PMP70 (mouse antibody) did not co-localize with Flag-SZT2 (mouse antibody), and (3) the localization of Flag-SZT2 on the lysosome was confirmed with rabbit anti-LAMP1 staining ( Fig. 3 and Extended Data Fig. 5a ). Size-exclusion chromatography (SEC). Near-confluent cells grown in 15-cm dishes were collected by scratching, washed once with ice-cold PBS, and lysed with 4 packed cell volumes of 1% Triton X-100 lysis buffer (1% Triton X-100, 50 mM HEPES (pH 7.4), 150 mM NaCl, 2.5 mM MgCl 2 , 10% glycerol and 1× EDTA-free protease inhibitor cocktail) on ice for 10 min. Lysates were spun at 20,000g for 20 min at 4 °C, and supernatants were filtered through a 0.22-μm Spin-X Centrifuge Tube Filter (Costar, 8160). 300 μl (3 mg) cleared supernatants were loaded on a Superose 6 Increase 10/300 GL Column (GE Healthcare, 29-0915-96) connected to a AKTA purifier (GE Healthcare), which was pre-equilibrated with 2 bed volumes (48 ml) of column buffer (50 mM HEPES (pH 7.4), 150 mM NaCl). The flow rate was 0.5 ml min −1 , and 0.5 ml fractions were collected. The column was calibrated with a High Molecular Weight Gel Filtration Calibration Kit (GE Healthcare, 28-4038-42) that contains: Blue Dextran 2000 (to determine void volume), ovalbumin (44 kDa), conalbumin (75 kDa), aldolase (158 kDa), ferritin (440 kDa) and thyroglobulin (669 kDa). Rat IgM (970 kDa, Jackson Immunoresearch, 009-00-012) was also included. The K AV value was calculated as: (elution volume−void volume)/(column volume−void volume). Ovalbumin (44 kDa) was not linear with other standard proteins on this column with our protocol and was therefore not included for calibration (Extended Data Fig. 2f ). Cleaning-in-place of column was performed after every 10 runs with 1 bed volume of 0.5 M sodium hydroxide, and the column was recalibrated after cleaning.
For immunoprecipitation with pooled fractions, every 4 fractions were pooled (from fraction 13). For each pool, protease inhibitor mixture was added to 1× and Triton X-100 was added to a final concentration of 1%. Subsequently, 2 μl of anti-WDR24 (Proteintech, 20778-1-AP) antibody was added and incubated for 2 h with rotation, then 20 μl (packed volume) of protein G beads was added for another 1 h. Beads were washed three times with lysis buffer containing 500 mM NaCl, once with lysis buffer with 150 mM NaCl, and boiled with 50 μl of 1× SDS sampling buffer for 5 min at 95 °C. Samples were subjected to SDS-PAGE and immunoblotting analysis. Sucrose density gradient centrifugation. Near-confluent cells grown in 15-cm dishes were collected by scratching, washed once with ice-cold PBS, and resuspended in 1 ml of homogenization buffer (10 mM Hepes (pH 7.4), 0.25 M/9% sucrose and 1× EDTA-free protease inhibitor) and incubated on ice for 10 min. Cells were broken by 20 strokes with a Dounce Tissue Grinder with a type-B pestle (KIMBLE, K885300-0002), and MgCl 2 and KCl were added to a final concentration of 1 mM and 100 mM, respectively. Unbroken cells were removed by centrifugation at 1,000g for 10 min at 4 °C, and the supernatant (1 ml) was layered on the top of a 9 ml sucrose density gradient of 0.4 M/13%-2.25 M/60% buffered in 10 mM HEPES (pH 7.4), which was poured using a gradient maker. The gradient was centrifuged at 100,000g for 4.5 h at 4 °C with an SW41 rotor using an Optima L-100 XP Ultracentrifuge (Beckman Coulter). Fractions were manually collected in 0.4 ml aliquots from the top of the gradient and subjected to SDS-PAGE and immunoblotting analysis.
Purification of the SOG complex. HEK293T SZT2
Flag/− cells were adapted to suspension growth in Freestyle 293 Expression Medium (Gibco, 12-338-026) in 2.8 l flasks on an orbital shaker (120 r.p.m.) placed in a humidified incubator with 8% CO 2 . All following steps were either on ice or at 4 °C, and all buffers were pre-chilled on ice. About 20 billion cells from a 6 l suspension culture were collected, washed once with ice-cold PBS, and lysed with 5 packed cell volumes of 1% Triton X-100 lysis buffer (1% Triton X-100, 50 mM HEPES (pH 7.4), 150 mM NaCl, 2.5 mM MgCl 2 , 10% glycerol and 1× EDTA-free protease inhibitor cocktail) on ice for 10 min. The lysate was spun at 20,000g for 10 min, the supernatant was further spun at 100,000g for 1 h. The supernatant was filtered through a 0.45-μm membrane and incubated with 100 μl (packed volume) of anti-Flag M2 beads for 1 h with gentle rotation. The beads were washed three times with wash buffer (0.1% Triton X-100, 50 mM HEPES (pH 7.4), 150 mM NaCl, 2.5 mM MgCl 2 , 10% glycerol) containing 2.5 mM ATP, then once with wash buffer. Bound proteins were eluted with wash buffer containing 0.5 mg ml −1 Flag peptide (Sigma, F3290) for 30 min with gentle rotation. Eluate was filtered through a 0.22-μm spin filter and directly loaded on the Superose 6 Increase 10/300 GL column for SEC, peak fractions containing SZT2 were pooled and concentrated to 50 μl with a centrifugal filter with a 50 kDa cut-off (Millipore, UCF205024). Then, 25 μl 3× SDS sampling buffer was added to the sample and boiled for 5 min at 95 °C, of which 60 μl was used for SDS-PAGE and silver staining with a SilverQuest Silver Staining Kit (Invitrogen, LC6070), and the rest was used for immunoblotting analysis of SOG components. Recombinant protein expression, purification and amino acid binding assay. Six million HEK293T cells or HEK293T sgSZT2 cells were plated in a 15-cm plate 24 h before transfection. 20 μg of pCMV-Flag-SZT2, pCDNA3.1-Flag-RFP, or pCD-NA3.1-Flag-SESN2 were transfected using Lipofectamine 2000 (Invitrogen). After 48 h of transfection, cells were lysed with 1% Triton X-100 lysis buffer (40 mM HEPES (pH 7.4), 1% Triton X-100, 10 mM β-glycerol phosphate, 10 mM pyrophosphate and 2.5 mM MgCl 2 ) supplemented with EDTA-free protease inhibitor and PhosSTOP. Subsequently, 50 μl of 50% slurry of anti-Flag M2 beads was added to the cleared lysates and incubated for 3 h at 4 °C with rotation. The beads were washed three times with the lysis buffer containing 500 mM NaCl, and once with binding buffer (0.1% Triton, 40 mM HEPES (pH 7.4), 10 mM NaCl, 150 mM KCl, 2.5 mM MgCl 2 ). The beads were equally split into seven aliquots (50 μl of each) for experiments. One aliquot was eluted with 50 μl of 100 mM glycine (pH 2.5) to check the purity of immunoprecipitates. The other six aliquots of beads were incubated with 2 μl (2 μCi) of 3 H-labelled leucine, arginine or glutamine on ice for 1 h in the presence or absence of 10 mM non-labelled leucine, arginine or glutamine, respectively. Tubes were flicked every five minutes. After incubation, the beads were spun down (3,000g for 1 min), and washed three times with wash buffer (0.1% Triton, 40 mM HEPES (pH 7.4), 150 mM NaCl). The beads were then resuspended Flag/− cells were deprived of amino acids for 1 h and stimulated with amino acids for 20 min where indicated. Cells were immunostained with anti-Flag (c-e), together with anti-LAMP2 plus anti-WDR59 (c), or anti-LAMP2 plus anti-EEA1 (d), or anti-RAB7 plus anti-PMP70 (e). f, Quantification of the co-localization among SZT2, PMP70, EEA1, RAB7, LAMP2 and WDR59. Data represent mean ± s.d. with 100 cells analysed for each condition. g, DEPDC5-deficient HEK293T cells were deprived of amino acids for 1 h and stimulated with amino acids for 20 min where indicated. The localization of WDR59 and LAMP2 was determined by immunostaining. h, Control, SZT2-deficient, DEPDC5-deficient and NPRL3-deficient cells were deprived of amino acids for 1 h and stimulated with amino acids for 20 min where indicated. Total cell lysates were analysed by immunoblotting. i, mRNA levels of DEPDC5 in control and DEPDC5-deficient HEK293T cells were measured by qPCR and normalized to β-actin. AU, arbitrary units. j, Control or SZT2-deficient HEK293T were treated with rapamycin (100 nM), deprived of amino acids for 1 h and stimulated with amino acids for 20 min where indicated. The localization of WDR59 and LAMP2 was determined by immunostaining. Data (a, b, g-j) are representative of three independent experiments.
